Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 30, 2015 9:31 PM ET

Commercial Services and Supplies

Company Overview of The Wellcome Trust Limited

Company Overview

The Wellcome Trust Limited is a not-for-profit organization that offers medical research charity services. The trust focuses on immunology and infectious disease, population and public health, neuroscience, physiological science, and genes and cells research services. The Wellcome Trust Limited was established in 1936 and is based in London, United Kingdom.

Gibbs Building

215 Euston Road

London,  NW1 2BE

United Kingdom

Founded in 1936

10 Employees


44 20 7611 8888


44 20 7611 8545

Key Executives for The Wellcome Trust Limited

Director of Wellcome Trust
Age: 62
Head of Legal and Operations
Director of Medicine, Society, and History
Head of Strategic Planning and Policy
Director of Resources
Compensation as of Fiscal Year 2015.

The Wellcome Trust Limited Key Developments

The Wellcome Trust Limited Presents at Bio-Trinity, May-11-2015

The Wellcome Trust Limited Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Basilea Pharma Inks License Agreement for Novel panRAF Kinase Inhibitors

Basilea Pharma announced that it has entered into a license agreement for novel panRAF kinase inhibitors with a consortium of organizations including The Institute of Cancer Research, London, Cancer Research Technology, the Wellcome Trust and The University of Manchester. The agreement grants Basilea exclusive global rights to develop, manufacture and commercialize novel panRAF kinase inhibitors which originate from research at The Institute of Cancer Research by scientists funded by Cancer Research UK and the Wellcome Trust. RAF kinases play an important role in tumor cell proliferation. The oral, small molecule panRAF inhibitors target BRAF and other growth pathways relied upon by resistant tumor cells. The consortium will lead clinical phase 1 development for the lead compound. Basilea will assume full operational responsibility thereafter. The consortium receives an upfront payment and is eligible to potential milestone payments on achievement of pre-specified clinical, regulatory and commercial milestones, as well as tiered royalties on future net sales.

The Wellcome Trust Limited Presents at 12th Annual BIO Asia International Conference, Mar-25-2015 11:30 AM

The Wellcome Trust Limited Presents at 12th Annual BIO Asia International Conference, Mar-25-2015 11:30 AM. Venue: Grand Hyatt Hotel, Tokyo, Japan.

Similar Private Companies By Industry

Company Name Region
Spaceworks Furniture Hire Limited Europe
High Court Enforcement Group Limited Europe
Shareholder Investments Research plc Europe
JBMI Group Ltd Europe
The Hyde Group Europe

Recent Private Companies Transactions

March 18, 2015
Exxon Mobil Corporation

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The Wellcome Trust Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at